Influence of ABO blood groups on susceptibility to SARS-CoV-2 infection
Keywords:
COVID-19, Coronavirus Infections, Blood Group Antigens, Risk, SARS-CoV-2, Susceptibility to Diseases.Abstract
Introduction: SARS-CoV-2 infection is associated with several risk factors that are classified as non-modifiable and modifiable; Within the non-modifiable ones, several authors have proposed ABO blood groups as an element to take into account. Objective: to describe the influence of ABO blood groups on susceptibility to SARS-CoV-2 infection. Material and Methods: a bibliographic review was carried out in the period from April to May 2021. The resources available in MEDLINE, SciELO, PubMed, Elsevier were used. Of 51 bibliographies found using the descriptors in health sciences, 25 bibliographic references were consulted that met the selection criteria. The synthetic analytical method was used. Development: after the first reports in the literature, the association between ABO blood group and SARS-CoV-2 infection has been investigated with variable results due to the fact that the reports suggest various studies carried out on populations from different countries including patients with underlying diseases; as well as mechanisms that postulate this association. Conclusions: studies indicate that ABO blood groups influence the risk of SARS-CoV-2 infection and several investigations also allow determining an effect of ABO phenotypes on the severity of the disease. Blood group O stands out as a protective factor compared to non-O blood groups.
Downloads
References
1. Habas K, Nganwuchu C, Shahzad F, Gopalan R, Haque M, Rahman S et al. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti Infect Ther[internet].2020[citado 2021 04 06];18(12): [aprox. 10 p.]. Disponible en: https://doi.org/10.1080/14787210.2020.1797487
2. Minsap.Parte de cierre del diá 3 de mayo de las 12 de la noche. [internet].2021[citado 2021 04 06].Disponible en:https://salud.msp.gob.cu/parte-de-cierre-del-dia-3-de-mayo-a-las-12-de-la-noche-2/
3. OMS.Actualización Epidemiológica Enfermedad por coronavirus(COVID-19)[internet].2021[citado 2021 04 06].Disponible en: https://www.paho.org/es/file/85719/download?token=tTijS0CG
4. Bertsch T, Lüdecke J, Antl W, Nausch LWM. Landsteiner K. The Discovery of the ABO Blood Group System and its Value for Teaching Medical Students. Clin Lab. [internet].2019 [citado 2021 04 06]; 65(6); [aprox. 8 p.]. Disponible en: https://doi.org/10.7754/Clin.Lab.2018.181218.
5. Liao H, Li J. Distribution characteristics of ABO and RhD blood groups among the voluntary blood donors in Chongqing: A retrospective study. Medicine (Baltimore) [internet]. 2020 [citado 2021 04 06]; 99(42):e22689. Disponible en: https://doi.org/10.1097/MD.0000000000022689.
6. Mahmud R, Rassel MA, Monayem FB, Sayeed SKJB, Islam MS, Islam MM et al. Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh. PLoS One[internet]. 2021[citado 2021 04 06];16(4):e0249252. Disponible en: https://doi.org/10.1371/journal.pone.0249252.
7. Guillon P, Clément M, Sébille V, Rivain JG, Chou CF, Ruvoën-Clouet N et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology[internet].2008 [citado 2021 04 06]18(12): [aprox. 8 p.]. Disponible en: https://doi.org/10.1093/glycob/cwn093.
8. Goel R, Bloch EM, Pirenne F, Al-Riyami AZ, Crowe E, Dau L et al. ISBT COVID-19 Working Group. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group. Vox Sang[internet]. 2021 [citado 2021 04 06]; 12:10.1111/vox.13076. Disponible en: https://doi.org/10.1111/vox.13076.
9. Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature[internet].2020[citado 2021 04 06];581(7807): [aprox. 10 p.].Disponible en: https://doi.org/10.1038/s41586-020-2180-5.
10. Sohlpour, A.; Jafari, A.; Pourhoseingholi, M.A.; Soltani, F. Corona COVID-19 virus and severe hypoxia in young patients without
underlying disease: High prevalence rate with blood group A. Trends Anesth. Crit. Care[internet]. 2020[citado 2021 04 06]; 34(2), [aprox. 1 p.] .Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428749/
11. Sardu, C.; Marfella, R.; Maggi, P.; Messina, V.; Cirillo, P.; Codella, V.; Gambardella, J.; Sardu, A.; Gatta, G.; Santulli, G.; et al.Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc. Disord. [internet]. 2020[citado 2021 04 06];20,373.Disponible en: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-020-01658-z
12. Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, Cooper J, Thiara S, Foster D, Chen LYC, Lee AYY, Conway EM, Wellington CL, Sekhon MS. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv[internet].2020 [citado 2021 04 06];4(20): [aprox. 8 p.]. Disponible en: https://doi.org/10.1182/bloodadvances.2020002623.
13. Muñiz-Diaz E, Llopis J, Parra R, Roig I, Ferrer G, Grifols J et al. Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients. Blood Transfus[internet].2021 [citado 2021 04 06];19(1): [aprox. 1 p.]. Disponible en: https://doi10.2450/2020.0256-20.
14. Kibler M, Dietrich L, Kanso M, Carmona A, Marchandot B, Matsushita K et al. Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients. J Clin Med[internet]. 2020 [citado 2021 04 06]; 9(11):3769. Disponible en: https://doi10.3390/jcm9113769.
15. Delanghe JR, De Buyzere ML, Speeckaert MM. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Eur J Prev Cardiol[internet]. 2020 [citado 2021 04 06];27(12): [aprox. 1 p.]. Disponible en: https://doi10.1177/2047487320931305.
16. Hodžić A, de la Fuente J, Cabezas-Cruz A. COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection? ACS Infect Dis[internet]. 2020 [citado 2021 04 06]; 6(12): [aprox. p.]. Disponible en: https://doi10.1021/acsinfecdis.0c00747.
17. Gallian P, Pastorino B, Morel P, Chiaroni J, Ninove L, de Lamballerie X. Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. Antiviral Res[internet]. 2020 [citado 2021 04 06]; 181:104880. Disponible en: https://doi10.1016/j.antiviral.2020.104880.
18. O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings DAT, Azman AS, Paireau J et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature[internet].2021[citado 2021 04 06];590(7844): [aprox. 5 p.]. Disponible en: https://doi10.1038/s41586-020-2918-0.
19. Priyadrasini, S.L.; Suresh, M. Factors influencing the epidemiological characteristics of pandemic COVID 19: A TISM approach. Int. J. Healthc. Manag[internet].2020[citado 2021 04 06];13(2):[aprox. 9 p.]. Disponible en: https://www.tandfonline.com/doi/full/10.1080/20479700.2020.1755804
20. Hatcher SM, Agnew-Brune C, Anderson M, Zambrano LD, Rose CE, Jim MA et al. COVID-19 Among American Indian and Alaska Native Persons - 23 States, January 31-July 3, 2020. MMWR Morb Mortal Wkly Rep[internet].2020 [citado 2021 04 06];69(34): [aprox. 3 p.]. Disponible en: https://doi10.15585/mmwr.mm6934e1.
21. Niles JK, Karnes HE, Dlott JS, Kaufman HW. Association of ABO/Rh with SARS-CoV-2 positivity: The role of race and ethnicity in a female cohort. Am J Hematol[internet].2021[citado 2021 04 06];96(1): [aprox. 3 p.]. Disponible en: https://doi10.1002/ajh.26019.
22. Ahmed I, Quinn L, Tan BK. COVID-19 and the ABO blood group in pregnancy: A tale of two multiethnic cities. Int J Lab Hematol[internet].2021[citado 2021 04 06];43(1): [aprox. 2 p.]. Disponible en: https://doi10.1111/ijlh.13355.
23. Latz CA, DeCarlo C, Boitano L, Png CYM, Patell R, Conrad MF et al. Blood type and outcomes in patients with COVID-19. Ann Hematol[internet]. [citado 2021 04 06];99(9): [aprox. 5 p.]. Disponible en: https://doi10.1007/s00277-020-04169-1.
24. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol[internet].2020 [citado 2021 04 06];190(1): [aprox. 2 p.]. Disponible en: https://doi10.1111/bjh.16797.
25. Barnkob MB, Pottegård A, Støvring H, Haunstrup TM, Homburg K, Larsen R et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Adv[internet]. 2020 [citado 2021 04 06];4(20): [aprox. 3 p.]. Disponible en: https://doi10.1182/bloodadvances.2020002657.
26. Focosi D, Carla IM, Lanza M. ABO Blood Group Correlations with Covid-19: Cohort Choice Makes A Difference. Clin Infect Dis[internet]. 2021[citado 2021 04 06];72(11):e919. Disponible en: https://doi10.1093/cid/ciaa1495.
27. Boudin L, Janvier F, Bylicki O, Dutasta F. ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults. Haematologica[internet].2020[citado 2021 04 06];105(12): [aprox. 2 p.]. Disponible en: https://doi10.3324/haematol.2020.265066.
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).
